Phase 2 and biomarker study of trebananib, an...

Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma

Reardon, David A., Lassman, Andrew B., Schiff, David, Yunus, Shakeeb A., Gerstner, Elizabeth R., Cloughesy, Timothy F., Lee, Eudocia Quant, Gaffey, Sarah C., Barrs, Jennifer, Bruno, Jennifer, Muzikans
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Cancer
DOI:
10.1002/cncr.31172
Date:
December, 2017
File:
PDF, 277 KB
english, 2017
Conversion to is in progress
Conversion to is failed